Hydrogels with integrin-binding angiopoietin-1-derived peptide, QHREDGS, for treatment of acute myocardial infarction

Circulation: Heart Failure

Volumn 8, Issue 2, 2015, Pages 333-341

  Reis, Lewis A ^a   Chiu, Loraine L Y ^b   Wu, Jun ^c   Feric, Nicole ^a   Laschinger, Carolc ^a   Momen, Abdul ^c   Li, Ren Ke ^c   Radisic, Milica ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

chitosan; collagen; hydrogel; myocardial infarction

Indexed keywords

BETA1 INTEGRIN; CHITOSAN; COLLAGEN; GLUTAMINYLHISTIDYLARGINYLGLUTAMYLASPARTYLGLYCYLSERINE; OLIGOPEPTIDE; TROPONIN T; UNCLASSIFIED DRUG; ANGIOPOIETIN 1; HYDROGEL; INTEGRIN; PEPTIDE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CELL SURVIVAL; CONTROLLED STUDY; DEGRADATION; DRUG DISTRIBUTION; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART FIBROBLAST; HEART FUNCTION; HEART MUSCLE CELL; HISTOLOGY; HYDROGEL; IN VIVO STUDY; LIFESPAN; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; RAT; ANIMAL; CHEMISTRY; DRUG EFFECTS; LEWIS RAT; MYOCARDIAL INFARCTION; PHARMACOLOGY;

ANGIOPOIETIN-1; ANIMALS; CHITOSAN; HYDROGELS; INTEGRINS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PEPTIDES; RATS, INBRED LEW;

EID: 84937579127     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001881     Document Type: Article

References (46)

1. Mayfield AE, Tilokee EL, Latham N, McNeill B, Lam BK, Ruel M, Suuronen EJ, Courtman DW, Stewart DJ, Davis DR. The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function. Biomaterials. 2014;35:133-142. doi: 10.1016/j. biomaterials.2013.09.085.
2. Nelson DM, Ma Z, Leeson CE, Wagner WR. Extended and sequential delivery of protein from injectable thermoresponsive hydrogels. J Biomed Mater Res A. 2012;100:776-785. doi: 10.1002/jbm.a.34015.
3. Menasché P. Current status and future prospects for cell transplantation to prevent congestive heart failure. Semin Thorac Cardiovasc Surg. 2008;20:131-137. doi: 10.1053/j.semtcvs.2008.03.001.
4. Lu WN, Lü SH, Wang HB, Li DX, Duan CM, Liu ZQ, Hao T, He WJ, Xu B, Fu Q, Song YC, Xie XH, Wang CY. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperatureresponsive chitosan hydrogel. Tissue Eng Part A. 2009;15:1437-1447. doi: 10.1089/ten.tea.2008.0143.
5. Rask F, Dallabrida SM, Ismail NS, Amoozgar Z, Yeo Y, Rupnick MA, Radisic M. Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells. J Biomed Mater Res A. 2010;95:105-117. doi: 10.1002/jbm.a.32808.
6. Garbern JC, Minami E, Stayton PS, Murry CE. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials. 2011;32: 2407-2416. doi: 10.1016/j.biomaterials.2010.11.075.
7. Suuronen EJ, Veinot JP, Wong S, Kapila V, Price J, Griffith M, Mesana TG, Ruel M. Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation. 2006;114(1 Suppl):I138-I144. doi: 10.1161/CIRCULATIONAHA.105.001081.
8. Zhang Y, Thorn S, DaSilva JN, Lamoureux M, DeKemp RA, Beanlands RS, Ruel M, Suuronen EJ. Collagen-based matrices improve the delivery of transplanted circulating progenitor cells: development and demonstration by ex vivo radionuclide cell labeling and in vivo tracking with positron-emission tomography. Circ Cardiovasc Imaging. 2008;1:197-204. doi: 10.1161/CIRCIMAGING.108.781120.
9. Wu J, Zeng F, Huang XP, Chung JC, Konecny F, Weisel RD, Li RK. Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. Biomaterials. 2011;32:579-586. doi: 10.1016/j.biomaterials.2010.08.098.
10. Deng C, Zhang P, Vulesevic B, Kuraitis D, Li F, Yang AF, Griffith M, Ruel M, Suuronen EJ. A collagen-chitosan hydrogel for endothelial differentiation and angiogenesis. Tissue Eng Part A. 2010;16:3099-3109. doi: 10.1089/ten.tea.2009.0504.
11. Fujita M, Ishihara M, Morimoto Y, Simizu M, Saito Y, Yura H, Matsui T, Takase B, Hattori H, Kanatani Y, Kikuchi M, Maehara T. Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction. J Surg Res. 2005;126:27-33. doi: 10.1016/j.jss.2004.12.025.
12. Reis LA, Chiu LL, Liang Y, Hyunh K, Momen A, Radisic M. A peptidemodified chitosan-collagen hydrogel for cardiac cell culture and delivery. Acta Biomater. 2012;8:1022-1036. doi: 10.1016/j.actbio.2011.11.030.
13. Tan W, Krishnaraj R, Desai TA. Evaluation of nanostructured composite collagen-chitosan matrices for tissue engineering. Tissue Eng. 2001;7:203-210. doi: 10.1089/107632701300062831.
14. Chiu LL, Iyer RK, Reis LA, Nunes SS, Radisic M. Cardiac tissue engineering: current state and perspectives. Front Biosci (Landmark Ed). 2012;17:1533-1550.
15. Reis LA, Chiu LLY, Feric N, Fu L, Radisic M. Injectable biomaterials for cardiac repair. In: Li R-K, Weisel RD, eds. Cardiac Regeneration & Repair Volume II: Biomaterials & Tissue Engineering. 1st ed. Cambridge, UK: Woodhead Publishing Ltd; 2014:528.
16. Hayes AJ, Huang WQ, Mallah J, Yang D, Lippman ME, Li LY. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res. 1999;58:224-237. doi: 10.1006/mvre.1999.2179.
17. Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. Circ Res. 2000;86:24-29.
18. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Li F, Altieri DC, Sessa WC. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem. 2000;275:9102-9105.
19. Carlson TR, Feng Y, Maisonpierre PC, Mrksich M, Morla AO. Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem. 2001;276:26516-26525. doi: 10.1074/jbc.M100282200.
20. Dallabrida SM, Ismail N, Oberle JR, Himes BE, Rupnick MA. Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ Res. 2005;96:e8-24. doi: 10.1161/01. RES.0000158285.57191.60.
21. Rask F, Mihic A, Reis L, Dallabrida SM, Ismail NS, Sider K, Simmons CA, Rupnick MA, Weisel RD, Li R-K, Radisic M. Hydrogels modified with QHREDGS peptide support cardiomyocyte survival in vitro and after sub-cutaneous implantation. Soft Matter. 2010;6:5089-5099.
22. Odedra D, Chiu LL, Shoichet M, Radisic M. Endothelial cells guided by immobilized gradients of vascular endothelial growth factor on porous collagen scaffolds. Acta Biomater. 2011;7:3027-3035. doi: 10.1016/j. actbio.2011.05.002.
23. Chiu LL, Weisel RD, Li RK, Radisic M. Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering. J Tissue Eng Regen Med. 2011;5:69-84. doi: 10.1002/term.292.
24. Chiu LL, Radisic M, Vunjak-Novakovic G. Bioactive scaffolds for engineering vascularized cardiac tissues. Macromol Biosci. 2010;10:1286-1301. doi: 10.1002/mabi.201000202.
25. Fan VH, Tamama K, Au A, Littrell R, Richardson LB, Wright JW, Wells A, Griffith LG. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells. 2007;25:1241-1251. doi: 10.1634/stemcells.2006-0320.
26. Shen YH, Shoichet MS, Radisic M. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater. 2008;4:477-489. doi: 10.1016/j. actbio.2007.12.011.
27. Patten RD, Aronovitz MJ, Deras-Mejia L, Pandian NG, Hanak GG, Smith JJ, Mendelsohn ME, Konstam MA. Ventricular remodeling in a mouse model of myocardial infarction. Am J Physiol. 1998;274(5 Pt 2):H1812-H1820.
28. Krzemiski TF, Nozyski JK, Grzyb J, Porc M. Wide-spread myocardial remodeling after acute myocardial infarction in rat. Features for heart failure progression. Vascul Pharmacol. 2008;48:100-108. doi: 10.1016/j.vph.2008.01.002.
29. Li Z, Guan J. Hydrogels for Cardiac Tissue Engineering. Polymers. 2011;3:740-761.
30. Kan CD, Li SH, Weisel RD, Zhang S, Li RK. Recipient age determines the cardiac functional improvement achieved by skeletal myoblast transplantation. J Am Coll Cardiol. 2007;50:1086-1092. doi: 10.1016/j. jacc.2007.06.009.
31. Matsubayashi K, Fedak PW, Mickle DA, Weisel RD, Ozawa T, Li RK. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation. 2003;108(suppl 1):II219-II225. doi: 10.1161/01.cir.0000087450.34497.9a.
32. Fan M, Chen W, Liu W, Du GQ, Jiang SL, Tian WC, Sun L, Li RK, Tian H. The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction. Rejuvenation Res. 2010;13:429-438. doi: 10.1089/rej.2009.0986.
33. Dang LT, Feric NT, Laschinger C, Chang WY, Zhang B, Wood GA, Stanford WL, Radisic M. Inhibition of apoptosis in human induced pluripotent stem cells during expansion in a defined culture using angiopoietin-1 derived peptide QHREDGS. Biomaterials. 2014;35:7786-7799. doi: 10.1016/j.biomaterials.2014.05.018.
34. Atala A, Lanza R, Thomson JA, Nerem RM. Principles of Regenerative Medicine. Amsterdam: Elsevier; 2008.
35. Feric N, Cheng CC, Goh MC, Dudnyk V, Di Tizio V, Radisic M. Angiopoietin-1 peptide QHREDGS promotes osteoblast differentiation, bone matrix deposition and mineralization on biomedical materials. Biomater Sci. 2014;2:1384-1398. doi: 10.1039/C4BM00073K.
36. Bouten CV, Dankers PY, Driessen-Mol A, Pedron S, Brizard AM, Baaijens FP. Substrates for cardiovascular tissue engineering. Adv Drug Deliv Rev. 2011;63:221-241. doi: 10.1016/j.addr.2011.01.007.
37. Das D, Zhang Z, Winkler T, Mour M, Gunter C, Morlock M, Machens HG, Schilling AF. Bioresorption and degradation of biomaterials. Adv Biochem Eng Biotechnol. 2012;126:317-333. doi: 10.1007/10-2011-119.
38. Ruggiero A, Thorek DL, Guenoun J, Krestin GP, Bernsen MR. Cell tracking in cardiac repair: what to image and how to image. Eur Radiol. 2012;22:189-204. doi: 10.1007/s00330-011-2190-7.
39. Yamaoka T, Tabata Y, Ikada Y. Body distribution profile of polysaccharides after intravenous administration. Drug Delivery. 1993;1:75-82.
40. Onishi H, Machida Y. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials. 1999;20:175-182.
41. Takemura G, Fujiwara H. Role of apoptosis in remodeling after myocardial infarction. Pharmacol Ther. 2004;104:1-16. doi: 10.1016/j. pharmthera.2004.07.005.
42. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W; American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108. doi: 10.1016/j.euje.2005.12.014.
43. Venugopal JR, Prabhakaran MP, Mukherjee S, Ravichandran R, Dan K, Ramakrishna S. Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface. 2012;9:1-19. doi: 10.1098/rsif.2011.0301.
44. Van Slyke P, Alami J, Martin D, Kuliszewski M, Leong-Poi H, Sefton MV, Dumont D. Acceleration of diabetic wound healing by an angiopoietin peptide mimetic. Tissue Eng Part A. 2009;15:1269-1280. doi: 10.1089/ten.tea.2007.0400.
45. Miklas JW, Dallabrida SM, Reis LA, Ismail N, Rupnick M, Radisic M. QHREDGS enhances tube formation, metabolism and survival of endothelial cells in collagen-chitosan hydrogels. PLoS One. 2013;8:e72956. doi: 10.1371/journal.pone.0072956.
46. Ahmad S, Cudmore MJ, Wang K, Hewett P, Potluri R, Fujisawa T, Ahmed A. Angiopoietin-1 induces migration of monocytes in a tie-2 and integrin-independent manner. Hypertension. 2010;56:477-483. doi: 10.1161/HYPERTENSIONAHA.110.155556.